1. Blood-based extracellular matrix biomarkers are correlated with clinical outcome after PD-1 inhibition in patients with metastatic melanoma. Issue 2 (22nd October 2020) Authors: Hurkmans, Daan P; Jensen, Christina; Koolen, Stijn L W; Aerts, Joachim; Karsdal, Morten Asser; Mathijssen, Ron H J; Willumsen, Nicholas Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Blood-based extracellular matrix biomarkers are correlated with clinical outcome after PD-1 inhibition in patients with metastatic melanoma. Issue 2 (22nd October 2020) Authors: Hurkmans, Daan P; Jensen, Christina; Koolen, Stijn L W; Aerts, Joachim; Karsdal, Morten Asser; Mathijssen, Ron H J; Willumsen, Nicholas Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Blood-based extracellular matrix biomarkers are correlated with clinical outcome after PD-1 inhibition in patients with metastatic melanoma. Issue 2 (22nd October 2020) Authors: Hurkmans, Daan P; Jensen, Christina; Koolen, Stijn L W; Aerts, Joachim; Karsdal, Morten Asser; Mathijssen, Ron H J; Willumsen, Nicholas Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Blood-based extracellular matrix biomarkers are correlated with clinical outcome after PD-1 inhibition in patients with metastatic melanoma. Issue 2 (22nd October 2020) Authors: Hurkmans, Daan P; Jensen, Christina; Koolen, Stijn L W; Aerts, Joachim; Karsdal, Morten Asser; Mathijssen, Ron H J; Willumsen, Nicholas Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Blood-based extracellular matrix biomarkers are correlated with clinical outcome after PD-1 inhibition in patients with metastatic melanoma. Issue 2 (22nd October 2020) Authors: Hurkmans, Daan P; Jensen, Christina; Koolen, Stijn L W; Aerts, Joachim; Karsdal, Morten Asser; Mathijssen, Ron H J; Willumsen, Nicholas Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Blood-based extracellular matrix biomarkers are correlated with clinical outcome after PD-1 inhibition in patients with metastatic melanoma. Issue 2 (22nd October 2020) Authors: Hurkmans, Daan P; Jensen, Christina; Koolen, Stijn L W; Aerts, Joachim; Karsdal, Morten Asser; Mathijssen, Ron H J; Willumsen, Nicholas Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Blood-based extracellular matrix biomarkers are correlated with clinical outcome after PD-1 inhibition in patients with metastatic melanoma. Issue 2 (22nd October 2020) Authors: Hurkmans, Daan P; Jensen, Christina; Koolen, Stijn L W; Aerts, Joachim; Karsdal, Morten Asser; Mathijssen, Ron H J; Willumsen, Nicholas Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Blood-based extracellular matrix biomarkers are correlated with clinical outcome after PD-1 inhibition in patients with metastatic melanoma. Issue 2 (22nd October 2020) Authors: Hurkmans, Daan P; Jensen, Christina; Koolen, Stijn L W; Aerts, Joachim; Karsdal, Morten Asser; Mathijssen, Ron H J; Willumsen, Nicholas Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Blood-based extracellular matrix biomarkers are correlated with clinical outcome after PD-1 inhibition in patients with metastatic melanoma. Issue 2 (22nd October 2020) Authors: Hurkmans, Daan P; Jensen, Christina; Koolen, Stijn L W; Aerts, Joachim; Karsdal, Morten Asser; Mathijssen, Ron H J; Willumsen, Nicholas Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Blood-based extracellular matrix biomarkers are correlated with clinical outcome after PD-1 inhibition in patients with metastatic melanoma. Issue 2 (22nd October 2020) Authors: Hurkmans, Daan P; Jensen, Christina; Koolen, Stijn L W; Aerts, Joachim; Karsdal, Morten Asser; Mathijssen, Ron H J; Willumsen, Nicholas Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗